Source: COVID-19 Drug Research Apr 14, 2020 2 years ago
COVID-19 Drug Research: More mounting evidence is emerging that both Choloroquine and Hydroxychloroquine have no clinical efficacy whatsoever for the treatment for COVID-19 and on the contrary can be actually dangerous and fatal for certain patients.
Choloroquine was first brought in the limelight by unprofessional and unregulated clinical studies conducted by certain Chinese researchers ...
Source: COVID-19 Pandemic News Apr 14, 2020 2 years ago
COVID-19 Pandemic: To add more confusion to the unknown characteristics of the SARS-CoV-2 coronavirus that scientists and medical experts are still trying to unravel, South Korea reported on Monday (13th April 13) that at least 116 people initially cleared of the new coronavirus had tested positive again, although officials suggested that they would soon look at easing strict recommendations aimed...
COVID-19 Drugs: This time a clinical trial of COVID-19 patients in Brazil ended early after patients taking a higher dose of chloroquine developed irregular heart rates. The clinical study was halted early for safety reasons after patients developed irregular heart rates that increased their risk of a potentially fatal heart arrhythmia.
The drug chloroquine is closely related to the more&...
Source: COVID-19 Diagnostics Apr 13, 2020 2 years ago
COVID-19 Diagnostics: The new antibody blood test kits for the SARS-CoV-2 coronavirus that causes the COVID-19 disease could play a key role in deciding whether millions of individuals can safely return to work and school. But US and EU public health officials are warning that many of these test kits have not been checked for accuracy and approved by regulatory bodies.
Example of a product...
Source: COVID-19 Research Apr 13, 2020 2 years ago
COVID-19 Research: When we are dealing with a new virus that there has not been much data or information till the last few 14 weeks, we should keep our options open when we are dealing with theories and hypothetic explanations as to date we have no confirmed prevention or treatment protocols nor vaccines except for lots of experimental drugs that have yet to have any proper clinical studies to sup...
Source: COVID-19 RESEARCH Apr 12, 2020 2 years ago
COVID-19 Research: A new study published in the journal Science reported that tests of the new SARS-CoV-2 coronavirus on domesticated cats, dogs, pigs, chickens, ducks and ferrets found that both cats and ferrets are highly susceptible to the virus. Cats can become infected through airborne transmission. It was observed however that dogs have a very low susceptibility to the vi...
Source: Thailand Coronavirus Updates Apr 11, 2020 2 years ago
Thailand Coronavirus Updates: While Thailand management of the COVID-19 crisis can be considered as excellent by the intellectually challenged in the sense to date, the country has only 2518 confirmed cases of the COVID-19 disease and only a mere 35 dead so far as claimed by local authorities, foreigners are bearing the brunt of upfront racialism and discrimination.
To date daily ca...
Source: COVID-19 Research Apr 11, 2020 2 years ago
COVID-19 Research Updates: A New Study Conducted in China by medical researchers from the Academy of Military Sciences, Tianjin, China and Wuhan’s Huoshenshan Hospital, and published in the US CDC’s Journal: Emerging Infectious Diseases, states the SARS-CoV-2 coronavirus could be found in air samples as far as 4 meters away from infected patients.
https://wwwnc.cdc.gov/eid/article/26/7...
Source: COVID-19 Drug Research Apr 11, 2020 2 years ago
COVID-19 Drug Research: For the past week, lots of media was abuzz about the results of an in vitro study by Australian researchers involving Ivermectin, a drug used to treat parasitic infections.
A single dose anti-parasitic drug was found to be able to stop the SARS-CoV-2 coronavirus from replicating in cells within 48 hours, according to findings from the vitro studies by Monash Univer...
Source: COVID-19 Supplements Apr 10, 2020 2 years ago
COVID-19 Supplements: The first clinical trial in the world trial will see researchers from Austin Health Teaching Hospital and the University of Melbourne use intravenous zinc to fight the symptoms of COVID-19 in infected patients.
The clinical trial will be led by Dr Joseph Ischia from Austin Health, along with Dr Oneel Patel from the Department of Surgery at the University of Melbourne...
Source: COVID-19 Research Apr 09, 2020 2 years ago
Dear Readers Certain Fact Checkers Contracted By Facebook Are Claiming That The Study Findings Are Incorrect And Fake And Have Also Affected Our Facebook Coverage Of This Article. We Shall Not However Take Down This Article As The Study Has Not Been Retracted And We Leave It Here For Readers To Do Their Own Due Diligence. (Note However We Have Been Penalized Unfairly By Certain American Bastards T...
Source: COVID-19 Clinical Care Apr 09, 2020 2 years ago
COVID-19 Clinical Care: Chloroquine, hydroxychloroquine and azithromycin are being used to ‘treat and prevent’ COVID-19 despite extremely little and weak evidence for effectiveness, and doctors, healthcare professionals and patients should be aware of these drugs' potentially serious adverse events, states a new report and announcement in CMAJ (Canadian Medical Asso...
Source: COVID-19 Vaccine Updates Apr 08, 2020 2 years ago
COVID-19 Vaccine Updates: To date, no vaccines exists that safeguard individuals against infections by the various coronaviruses, including SARS-CoV-2, which causes the COVID-19 disease, or the ones that cause SARS and MERS. As COVID-19 continues to wreak havoc, many research laboratories around the world have developed a targeted focus on understanding the virus and finding the best strategy for ...
COVID-19 Updates: China leading COVID-19 expert, Dr Zhang Wenhong has publicly warned that a second wave of the COVID-19 pandemic is gradually emerging in China and warns that it could far more worse than the first. His warnings echo the calls from many other Chinese medical professionals who are claiming that despite massive cover-ups by the Chinese government, some even more sophisticated than i...
Source: COVID-19 Research Apr 07, 2020 2 years ago
COVID-19 Research: In a rare case study in Renmin Hospital of Wuhan University, medical researches came across a 66 year old male patient that had developed post-infectious acute myelitis.
Acute myelitis or sometimes called acute flaccid myelitis (AFM) is a rare but serious neurologic condition. It affects the nervous system, specifically the area of the spinal cord called gray matter, wh...
COVID-19: Dr Michael Mina, an Assistant Professor of Epidemiology at the Harvard T.H. Chan School of Public Health and its Center for Communicable Disease Dynamic has announced that the SARS-CoV-2 coronavirus that causes COVID-19 is more transmissible than previously thought.
To date, it has been difficult to keep it from spreading in a number of settings, including hospitals, cruise ships, and...
Source: COVID-19 Supplements Apr 07, 2020 2 years ago
COVID-19 Supplements: Medical researchers from The Irish Longitudinal Study on Ageing (TILDA) at Trinity College Dublin have released a new crucial report in response to the COVID-19 global crisis. https://tilda.tcd.ie/publications/reports/pdf/Report_Covid19VitaminD.pdf
The medical report: "Vitamin D deficiency in Ireland—implications for COVID-19. Results from the Irish Longit...
Source: COVID-19 Drug Research Apr 07, 2020 2 years ago
COVID-19 Drug Research: A new drug called EIDD-2801 developed by medical researchers from University Of North Carolina, Chapel Hill could change the way doctors treat COVID-19. The drug shows promise in reducing lung damage, has finished testing in animal models such as mice and will shortly be moving into human clinical trials.
To date, the new SARS-CoV-2 coronavirus had infected more th...
COVID-19: Thailand Medical News has always been the forefront of breaking the latest credible research and developments with regards to the COVID-19 disease and often it is a grim picture. Our intention is not to cause panic or make things even more depressing but rather for medical researchers and healthcare professionals to be aware or issues so that solutions can be found and precautions taken....
A new study published in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine identifeis the most common characteristics of 85 COVID-19 patients who died in Wuhan, China in the early stages of the coronavirus pandemic. The study reports on commonalities of the largest group of coronavirus patient deaths to be studied to date. https://www.atsjournals.o...
Source: COVID-19 Drug Research Apr 04, 2020 2 years ago
COVID-19 Drug Research: A study just published in a French medical journal provides new evidence that hydroxychloroquine does not appear to help the immune system clear the coronavirus from the body. https://www.sciencedirect.com/science/article/pii/S0399077X20300858?via%3Dihub
The study comes on the heels of two others one in France and one in China that reported some benefits i...
The SARS-CoV-2 coronavirus that causes the deadly Covid-19 disease could even spread through the air via normal breathing and speaking, a top US scientist said on Friday as the American government was poised to recommend the use of face masks for everyone.
Dr Anthony Fauci, head of infectious diseases at the National Institutes of Health, told Fox News the guidance on masks would be chang...
Source: COVID-19 Research Apr 03, 2020 2 years ago
COVID-19 Research: A major collaboration of international experts from various medical, genomic and biological fields lead by Northeastern's Center for Complex Network Science Research has identified that the SARS-Cov-2 coronavirus is able to target 332 human proteins and also has a variety of binding sites, not just the four that was initially discovered including ACE-2 receptors.
&nb...
Source: Covid-19 Vaccine Updates Apr 03, 2020 2 years ago
Covid-19 Vaccine Updates: Medical, virology and genomic researchers from the University of Pittsburgh School of Medicine have reported a potential vaccine against SARS-CoV-2 coronavirus that causes the deadly Covid-19 disease. https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(20)30118-3/fulltext
The vaccine when tested in animal models such as mice, the vaccine, delivered throu...
COVID-19: Despite an early warning by Thailand Medical News in an article published 5th Of March 2020 that the SARS-Cov-2 coronavirus that causes the Covid-19 disease could cause harm to the nervous system and also the brain, https://www.thailandmedical.news/news/breaking-news-coronavirus-can-also-attack-the-nervous-system,-causing-neurological-conditions-and-even-viral-encephalitis ,many ignorant...
Source: Covid-19 Clinical Care Apr 03, 2020 2 years ago
Covid-19 Clinical Care: As the global number of infected cases of Covid-19 has already hit more than the one million mark as of Friday morning (9.30am Bangkok, 3rd April) ie 1,015,082 cases and the total number of deaths has now reached 53,207, researchers and medical experts are frantically trying to find treatments and cures and many existing drugs are being repurposed and placed as experimental...
Source: Covid-19 Drug Research Apr 02, 2020 2 years ago
Covid-19 Drug Research: European pharmaceutical giant, APEIRON Biologics AG today announced that it has received regulatory approvals in Austria, Germany and Denmark to initiate a Phase II clinical trial of APN01 to treat Covid-19. APN01 is the recombinant form of the human angiotensin-converting enzyme 2 (rhACE2), and has the potential to block the infection of cells by the novel SARS-CoV-2 virus...
Source: Covid-19 Clinical Care Apr 02, 2020 2 years ago
Covid-19 Clinical Care: Medical researchers and ophthalmologists from the Department of Ophthalmology, The First College of Clinical Medical Science, Yichang Central People’s Hospital, Zhongshan Ophthalmic Center and Sun Yat-Sen University have published findings form a new study that shows that almost a third of Covid-19 patients exhibit ocular abnormalities.
Previous studies on clin...
Source: Covid-19 Diagnostics Apr 02, 2020 2 years ago
Covid-19 Diagnostics: According to a new study by Chinese researchers from Wuhu Public Hospitals In Anhui, updated CT scan scoring criteria that considers lobe involvement, as well as changes in CT scan findings, could quantitatively and accurately evaluate the progression of theCovid-19 pneumonia. https://www.ajronline.org/doi/10.2214/AJR.20.23078
CT scoring criteria were applied to images from...
Source: Covid-19 Prevention Apr 01, 2020 2 years ago
Covid-19 Prevention: Many are still wondering who is the charlatan who came the idea that social distancing of 1 to 3 meters would suffice to prevent the spread of the SARS CoV-2 coronavirus despite no official scientific studies to show that it true and is fully safe.
To make matters worse, since the beginning of this Covid-19 breakout, we have allowed government authorities, healt...
Source: Thailand Coronavirus News Apr 01, 2020 2 years ago
Thailand Coronavirus Updates: The Covid-19 crisis is expected to worsen in Thailand over the next few weeks basically due to irresponsibility of locals and lack of discipline as many do not understand the importance of self-isolation, social distancing and taking necessary precautions.
Even worst are selfish individuals who when experiencing symptoms , instead of either going to a hospita...
Source: Thailand Medical News Apr 01, 2020 2 years ago
Covid-19 Research: A novel protocol brings the hope of new therapeutic options for suppressing seasonal influenza, avian flu and even the Covid-19 by utilizing an empty and therefore non-infectious shell of a phage virus to block biding sites of these viruses.
Phage shell docks on surface of virus and inhibits it . Credit: Barth van Rossum / FMP
German researchers from the Leibniz-Forschu...
Source: Thailand Medical News Mar 31, 2020 2 years ago
Covid-19 Research: Chinese researchers have been exploring the usage of stem cells to treat the Covid-19 disease since late January when a team of researchers from Baoshan Hospital and Peking University lead by Dr Bing Liang used mesenchymal stem cells from human umblical cord to treat a 65 year old female patient who was in critical condition. file:///C:/Users/Administrator/Downloads/202002.00084...
Source: Covid-19 Research Mar 31, 2020 2 years ago
Covid-19 Research: A new study published in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine gives a warning that majority of patients who are clinically recovered were still found to be infectious with the SARS-CoV-2 coronavirus that causes the deadly Covid-19 disease.
The medical researchers found that half of the patients they treated for...
Covid-19 Warning: A joint statement published March 26 by the American Society of Anesthesiologists, Society of Critical Care Medicine, American Association for Respiratory Care, Anesthesia Patient Safety Foundation, American Association of Critical‐Care Nurses, and American College of Chest Physicians warns that the sharing of mechanical ventilators should not be attempted during the Covid-19 &nb...
As the Covid-19 cases are escalating exponentially globally, with almost 739,385 confirmed infected cases and 35,128 deaths reported as of 2100 Hrs (Bangkok, 30th April 2020) and millions more infected awaiting testing, and one quarter of the planet sheltered in their homes to help quell the outbreak, many are asking the obvious question: How long will all this last?
Associate Professor D...
Source: Covid-19 Clinical Care Mar 30, 2020 2 years ago
Covid-19 Clinical Care: A new study conducted by medical researchers from Nanjing Medical University involving three hospitals and more than 1314 Covid-19 patients of which the focus was on 83 critically ill patients revealed that almost 86 percent or more of these critically ill patients suffered from acute gastrointestinal injury (AGI) .
This observed phenomenon indicated that SARS-CoV-...
Source: Thailand Medical News Mar 30, 2020 2 years ago
Covid-19 Drug Research: Sarilumab or Kevzara, a human monoclonal antibody that was jointly developed Regeneron and Sanofi and is able to inhibit the production of a cytokine called interleukin-6 (IL-6), which has been observed in cases of pneumonia in some Covid-19 patients will be used in the first approved clinical trial in New York for Covid-19 patients.
Cytokines are small proteins th...
US Covid-19 News: It saddens many to see how the Covid-19 crisis has quickly escalated in America despite being the world’s leader in medical research and healthcare facilities. In about slightly more than three weeks, the number of cases has spiraled to 141,854 confirmed infected cases with millions more suspected cases yet to be tested and 2,502 deaths so far as of Monday morning (Bangkok)...
Covid-19: We have been observing the situation in your respective countries and we are deeply saddened by the rising numbers.
Our advise to all, please self isolate if you can, do not even practice social distancing as keeping away from each other for 1 to 3 meters is not going to help much due the potent transmissibility of the virus and its long survival period in the air and surf...
Source: Covid-19 Drug Research Mar 29, 2020 2 years ago
Covid-19 Drug Research: The global medical industry has in the past months evolved into a ‘Wild Wild West’ or ‘circus’ with more unprecedented and unprofessional medical practices being conducted as a result of the Covid-19 crisis. Experimental drugs that have not been properly evaluated are being adopted as main treatment protocols in certain countries merely based on cert...
Source: Thailand Covid-19 News Mar 28, 2020 2 years ago
While the world is dealing with the Covid-19 crisis that originated from China, most were not aware that another new zoonotic virus has emerged in China and it reported on the 24th Of March that a male worker was on the way to work to Shandong along with 29 other people on a chartered bus on Sunday began to feel unwell on the way and was sent to hospital in Ningshan county, Shannxi Province ...
Source: Covid-19 Research Mar 28, 2020 2 years ago
Covid-19 Research: A team of medical researchers from Columbia University Medical Center, New York University Langone Health, Uconn Health and the University of Bordeaux have identified a novel group of immune cells in the lungs that are associated with the control of inflammation during viral infections, like influenza or coronavirus infections. https://immunology.sciencemag.org/content/5/4...
Source: Covid-19 Clinical Care Mar 28, 2020 2 years ago
Covid-19 Clinical Care: Cardiology researchers from the University of Texas Health Science Center at Houston or UTHealth are warning that the SARS-CoV -2 coronavirus that causes the Covid-19 disease can have fatal consequences for people with underlying cardiovascular disease and cause cardiac injury even in patients without underlying heart conditions.
The new research paper was be...
Source: SARS-CoV-2 Genomic Studies Mar 28, 2020 2 years ago
SARS-CoV-2 Genomic Studies: Thailand Medical News has managed to convinced more international genomic researchers to pay attention to the mutations and emerging strains of the SARS-CoV-2 coronavirus as in the past despite gene sequencing of strains that were detected in respective countries, many of these results were not properly compared and analyzed in detail to understand the evolutionary bran...
Source: SARS-Cov-2 Research Mar 27, 2020 2 years ago
SARS-Cov-2 Research: Dr James Diaz, Professor and Head of Environmental Health Sciences at Louisiana State University Health and New Orleans School of Public Health, has proposed a possible explanation for the severe lung complications being seen in some people diagnosed with Covid-19.
His research findings was published in the Journal of Travel Medicine. https://academic.oup.com/jtm...
Source: Covid-19 Clinical Care Mar 27, 2020 2 years ago
Covid-19 Clinical Care: Medical researchers from the University of Colorado at Denver and MIT have proposed a new stopgap measure that could help Covid-19 patients who are in acute respiratory distress by repurposing a drug that is now used to treat blood clots. The researchers believe the drug could help patients in cases where a ventilator is not helping, or if a ventilator is not available.
...
According to a research letter published online March 25 in JAMA Oncology, patients with cancer in Wuhan had an increased risk for severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infections. The journal warns that similar issues could also affect cancer patients elsewhere. (https://jamanetwork.com/journals/jamaoncology/fullarticle/2763673)
Dr Jing Yu, M.D., from the Zhon...
In Spain, doctors are being forced due to time constrains, staff shortages, inadequate medical supplies to choose who to let live and who to die in a sad state of affairs that is becoming common in many part of the world.
Dr Daniel Bernabeu signed the death certificate for one patient and immediately turned to help another who was choking, in the emergency room at one of Madrid's bigg...
As predicted by Thailand Medical News in our earlier articles, we have reached more than 22,048 deaths and almost half a million are infected for this week.
Despite reporting on so many developments since December, they are many out there not taking us seriously some even labeling a lot of what we are saying as fake news despite supporting research studies. It seems that many disillusioned soul...
Philippines Medical Association announced on Thursday that nine doctors have died in the Philippines from the Covid-19, as hospitals were overwhelmed and medics complained about a lack of protection on the front lines.
The official announcement of the doctors' deaths heightened fears that the scale of the health crisis in the Philippines is much worse than is being officially reported, with...
Source: Covid-19 Drug Research Mar 26, 2020 2 years ago
Covid-19 Drug Research: A study conducted by researchers from the Department of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai has shown that Hydroxychloroquine, an antimalarial drug dubbed a "gift from God" by US President Donald Trump for its potential ability to fight the Covid-19 disease, was found to be no more effective than standard trea...
Source: Covid-19 Clinical Care Mar 26, 2020 2 years ago
Covid-19 Clinical Care: As the SARS-CoV-2 coronavirus that causes the deadly Covid-19 disease continues to wreak havoc globally with more than 21,500 deaths to date, the possibility of a vaccine or cure seems far away, maybe in only 15 to 18 months time as efforts are being hampered by a variety of reasons and factors including the fact that the SARS-CoV-2 coronavirus is mutating with the emergenc...
We at Thailand Medical News are proud to republished an original news article by by Olivier Lucazeau and Antoine Bouthier from AFP featuring a remarkable doctor with true passion for healing unlike those clueless medical experts sitting in the comfort of their aircon offices and trying to dictate policies and protocols while being clueless about the macro and micro perspectives of the disease.
P...
Source: Covid-19 Clinical Care Mar 25, 2020 2 years ago
Covid-Clinical Care: Medical researchers are reporting that Initiation of extracorporeal membrane oxygenation (ECMO) may result in decreases in lymphocyte numbers and immunity function, which can be associated with increased severity of Covid-19.
Extracorporeal membrane oxygenation (ECMO), also known as extracorporeal life support (ECLS), is an extracorporeal tech...
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
